Maternal BCG primes for enhanced health benefits in the newborn - 02/03/22
, Christian Bjerregård Øland a, Mike Berendsen a, b, c, Morten Bjerregaard-Andersen a, Elise Brenno Stjernholm a, Christian N Golding a, Ivan Monteiro a, Peter Aaby a, Christine Stabell Benn a, b, d, ⁎ Highlights |
• | In RCTs, neonatal BCG provided protection against non-TB infections. |
• | Neonatal BCG vaccination especially reduced the risk of fatal neonatal sepsis. |
• | Recent studies have associated maternal BCG scars with improved offspring outcomes. |
• | In a cohort of 10,598 newborns, maternal BCG scar halved the risk of fatal sepsis. |
• | The protection inferred by maternal BCG was particularly strong for male newborns. |
Summary |
Objectives |
Bacille Calmette-Guérin (BCG) vaccination lowers the risk of severe infection; we tested whether effects are modulated by maternal BCG in a large cohort of BCG-vaccinated newborns from Guinea-Bissau.
Methods |
Maternal BCG scar status were inspected at enrolment in a BCG trial conducted from 2014 to 17 in Bissau, Guinea-Bissau. We tested associations with background factors for potential confounding; maternal age affected effect estimates >5% and accordingly, all analyses were adjusted for maternal age. Hospitalization data was collected prospectively and assessed in Cox-models providing adjusted Incidence Rate Ratios (aIRRs). In-hospital risk of death (case-fatality) risk was assessed using binomial regression providing adjusted Risk Ratios (aRRs).
Results |
60% (6,309/10,598) of mothers had a scar. The maternal-scar/no-scar admission aIRR was 0.96 (0.81–1.14) from 0 to 6 weeks and 1.12 (0.97–1.28) for 6 weeks-3 years. The 6-week in-hospital case-fatality infection aRR was 0.59 (0.34–1.05); 0.40 (0.17–0.91) for males and 0.86 (0.38–1.94) for females. Protection was especially evident against sepsis, the overall 6-week aRR=0.49 (0.26–0.91); no effect was observed for non-infectious deaths or after 6 weeks of age. Effects were similar across BCG strains and multivariate models adjusted for socioeconomic status did not affect estimates.
Conclusion |
Among BCG-vaccinated newborns, there was a trend for fewer in-hospital deaths from infection associated with maternal BCG priming, especially for males. Providing BCG to adults without a vaccination scar might enhance their offspring's capacity to handle severe infections.
Brief 40-word summary: Within a trial comparing BCG strains for their overall effects on morbidity and mortality in Guinea-Bissau, vertical priming with BCG (represented by the maternal BCG scar) was associated with beneficial sex-differential effects on offspring survival.
Le texte complet de cet article est disponible en PDF.Keywords : Bacille Calmette-Guérin (BCG), Live-vaccines, Early-life morbidity and mortality, Vertical priming, Maternal BCG priming, Non-specific effects of vaccines
Plan
Vol 84 - N° 3
P. 321-328 - mars 2022 Retour au numéro
Article précédent
- Impact of antibiotic use on patient-level risk of death in 36 million hospital admissions in England
- Eric P Budgell, Timothy J Davies, Tjibbe Donker, Susan Hopkins, David H Wyllie, Tim E A Peto, Martin J Gill, Martin J Llewelyn, A Sarah Walker
- Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
- Maria Paz Ventero, Oscar Moreno-Perez, Carmen Molina-Pardines, Andreu Paytuví-Gallart, Vicente Boix, Isabel Escribano, Irene Galan, Pilar González-delaAleja, Mario López-Pérez, Rosario Sánchez-Martínez, Esperanza Merino, Juan Carlos Rodríguez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?